Intravenous immunoglobulins for relapses of systemic vasculitides associated with antineutrophil cytoplasmic autoantibodies: Results of a multicenter, prospective, open-label study of twenty-two patients-Reference-Cited by-同舟云学术

Intravenous immunoglobulins for relapses of systemic vasculitides associated with antineutrophil cytoplasmic autoantibodies: Results of a multicenter, prospective, open-label study of twenty-two patients

Published:2007 Issue:1 Volume:58 Page:308-317
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis Rheum

Author:

Martinez Valérie,Cohen Pascal,Pagnoux Christian,Vinzio Stéphane,Mahr Alfred,Mouthon Luc,Sailler Laurent,Delaunay Claire,Sadoun Alain,Guillevin Loïc,

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference41 articles.

1. AUTOANTIBODIES AGAINST NEUTROPHILS AND MONOCYTES: TOOL FOR DIAGNOSIS AND MARKER OF DISEASE ACTIVITY IN WEGENER'S GRANULOMATOSIS

2. A Randomized Trial of Maintenance Therapy for Vasculitis Associated with Antineutrophil Cytoplasmic Autoantibodies

3. A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized wegener's granulomatosis

4. An interdisciplinary approach to the care of patients with Wegener's granulomatosis: Long-term outcome in 155 patients

5. Treatment of systemic vasculitis with pooled intravenous immunoglobulin

Cited by 146 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Update on targeted treatments for ANCA-associated vasculitis;Joint Bone Spine;2025-01

2. Peculiar features of intravenous immunoglobulins application in rheumatic diseases;Modern Rheumatology Journal;2024-06-15

3. Intravenous immunoglobulin therapy in antineutrophil cytoplasmic antibody-associated vasculitis;European Journal of Internal Medicine;2023-11

4. Biologic therapy in large and small vessels vasculitis, and Behçet’s disease: Evidence- and practice-based guidance;Autoimmunity Reviews;2023-08

5. Long-term mepolizumab treatment reduces relapse rates in super-responders with eosinophilic granulomatosis with polyangiitis;Allergy, Asthma & Clinical Immunology;2023-05-13